Literature DB >> 9884070

Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.

A S Zwart1, E A Davis, R E Widdop.   

Abstract

The aim of this study was to characterize the angiotensin II receptors in isolated uterine arteries from non pregnant and pregnant rats, since it has been reported from binding studies that ovine uterine arteries contain AT2 receptors. Uterine arterial segments were obtained from virgin, non-pregnant and late pregnant (18-21 days) Sprague-Dawley rats and mounted in small vessel myographs. Concentration-response curves were constructed to angiotensin II (1 nM-10 microM) in the absence and presence of various angiotensin II receptor subtype selective compounds. These included losartan (AT1 antagonist; 1, 10 and 100 nM), PD 123319 (AT2 antagonist; 1 microM) and CGP 42112 (AT2 agonist; 1 microM). Responses to angiotensin II were measured as increases in force (mN) and expressed as a per cent of the response to a K+ depolarizing solution. Losartan (1, 10 and 100 nM) caused significant concentration-dependent rightward shifts of the angiotensin II concentration-response curve in uterine arteries from non-pregnant and pregnant rats. The pA2 values calculated from these data were 9.8 and 9.2, respectively, although the slope of the Schild plot in the non-pregnant group was less than unity. PD 123319 (1 microM) caused significant 6- and 3 fold leftward shifts of the angiotensin II concentration-response curve in uterine arteries from non-pregnant and pregnant rats, respectively. In vessels from pregnant rats, PD 123319 also significantly increased the maximum response to angiotensin II. CGP 42112 (1 microM) attenuated the response to angiotensin II of uterine arteries from non-pregnant rats. This was reflected by a 14 fold rightward shift of the angiotensin II concentration-response curve and a decrease in the maximum response. In uterine arteries from pregnant rats, CGP 42112 (1 microM) caused a 3 fold rightward shift of the angiotensin II concentration-response curve, but had no effect on the maximum response. PD 123319 (1 microM) and CGP 42112 (1 microM) had no effect on the concentration-response curves to phenylephrine (PE) of uterine arteries from non-pregnant or pregnant rats. In addition, CGP 42112 (1 nM-1 mM) had no vasodilator effect on tissues precontracted with phenylephrine. These results suggest that the contractile responses of the rat uterine artery are mediated by the AT1 receptor. Furthermore, in this vascular preparation, the AT2 receptor appears to inhibit the response mediated by the AT1 receptor, although, this is not uniform between the non-pregnant and pregnant states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884070      PMCID: PMC1565725          DOI: 10.1038/sj.bjp.0702210

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Vasoconstriction is determined by interstitial rather than circulating angiotensin II.

Authors:  Martin P Schuijt; René de Vries; Pramod R Saxena; Maarten A D H Schalekamp; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

3.  Defining the differential sensitivity to norepinephrine and angiotensin II in the ovine uterine vasculature.

Authors:  Charles R Rosenfeld; Kevin DeSpain; Xiao-tie Liu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

4.  Gestational modification of murine spiral arteries does not reduce their drug-induced vasoconstrictive responses in vivo.

Authors:  Sean Leonard; Patricia D A Lima; B Anne Croy; Coral L Murrant
Journal:  Biol Reprod       Date:  2013-12-12       Impact factor: 4.285

5.  Differential sensitivity to angiotensin II and norepinephrine in human uterine arteries.

Authors:  Charles R Rosenfeld; Kevin DeSpain; R Ann Word; Xiao-tie Liu
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

6.  Estrogen Receptor-β Mediates Estradiol-Induced Pregnancy-Specific Uterine Artery Endothelial Cell Angiotensin Type-2 Receptor Expression.

Authors:  Jay S Mishra; Gigi M Te Riele; Qian-Rong Qi; Thomas J Lechuga; Kathirvel Gopalakrishnan; Dong-Bao Chen; Sathish Kumar
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

7.  AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.

Authors:  Xiao C Li; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

8.  Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta.

Authors:  Ruth E Hannan; Tracey A Gaspari; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

9.  Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide.

Authors:  Ruth E Hannan; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

10.  Uteroplacental insufficiency programmes vascular dysfunction in non-pregnant rats: compensatory adaptations in pregnancy.

Authors:  Marc Q Mazzuca; Marianne Tare; Helena C Parkington; Nicoleta M Dragomir; Laura J Parry; Mary E Wlodek
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.